checkAd
    Startseite > Aktien > Silence Therapeutics > Nachrichten
    Silence Therapeutics Aktie
    19,200
     
    EUR
    +1,59 %
    +0,300 EUR
    Letzter Kurs 31.05.24 Frankfurt
    19,200
     
    EUR
    157 STK
    Geldkurs 31.05.24
    19,500
     
    EUR
    154 STK
    Briefkurs 31.05.24
    ISIN: US82686Q1013 · WKN: A2QB4J · SYM: XRP2 · Großbritannien

    Neueste Nachrichten

    Silence Therapeutics to Present at Jefferies Global Healthcare Conference
    30.05.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics Reports First Quarter 2024 Results and Highlights Pipeline Progress
    16.05.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference
    30.04.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors
    29.04.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
    08.04.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
    13.03.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)
    13.03.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024
    28.02.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial
    23.02.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics Announces Oversubscribed $120 Million Private Placement
    05.02.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
    31.01.24 · Business Wire (engl.) · Silence Therapeutics
    Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments
    01.12.23 · Business Wire (engl.) · Silence Therapeutics